To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The contract vivarium (CV) model is rapidly gaining ...
The SMART2 model for estimating recurrent CV risk is well-calibrated overall but slightly underestimates risk in patients ...
Optimizing biomarker testing and targeted therapy integration in early-stage NSCLC: A quality improvement initiative at community oncology clinics. CVRFs in candidates for ProActive-CV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results